Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype

Computational Modeling for Antiarrhythmic Drugs for Atrial Fibrillation According to Genotype

Background: The efficacy of antiarrhythmic drugs (AAD) can vary in patients with atrial fibrillation (AF), and the PITX2 gene affects the responsiveness of AADs. We explored the virtual AAD (V-AAD) responses between wild-type and PITX2+/−-deficient AF conditions by realistic in silico AF modeling.Me...

Full description

Bibliographic Details
Main Authors:	Inseok Hwang, Ze Jin, Je-Wook Park, Oh-Seok Kwon, Byounghyun Lim, Myunghee Hong, Min Kim, Hee-Tae Yu, Tae-Hoon Kim, Jae-Sun Uhm, Boyoung Joung, Moon-Hyoung Lee, Hui-Nam Pak
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Series:	Frontiers in Physiology
Subjects:	atrial fibrillation modeling antiarrhythmic drugs PITX2 gene
Online Access:	https://www.frontiersin.org/articles/10.3389/fphys.2021.650449/full

Similar Items

Corrigendum: Computational modeling for antiarrhythmic drugs for atrial fibrillation according to genotype
by: Inseok Hwang, et al.
Published: (2022-12-01)

Ablation and antiarrhythmic drug effects on PITX2+/− deficient atrial fibrillation: A computational modeling study
by: Ze Jin, et al.
Published: (2022-07-01)

Spatial Changes in the Atrial Fibrillation Wave-Dynamics After Using Antiarrhythmic Drugs: A Computational Modeling Study
by: Inseok Hwang, et al.
Published: (2021-09-01)

Corrigendum: Spatial changes in the atrial fibrillation wave-dynamics after using antiarrhythmic drugs: A computational modeling study
by: Inseok Hwang, et al.
Published: (2022-12-01)

Cost-effectiveness of rhythm control strategy: Ablation versus antiarrhythmic drugs for treating atrial fibrillation in Korea based on real-world data
by: Woojin Kim, et al.
Published: (2023-01-01)

Computational modeling of atrial fibrillation
by: Oh-Seok Kwon, et al.
Published: (2021-12-01)

US Antiarrhythmic Drug Treatment for Patients With Atrial Fibrillation: An Insurance Claims–Based Report
by: Jonathan G. Tardos, et al.
Published: (2021-03-01)

Current strategies of antiarrhythmic drug therapy for paroxysmal atrial fibrillation
by: Takashi Komatsu
Published: (2012-06-01)

Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms
by: Meng Geng, et al.
Published: (2020-11-01)

Nationwide survey of catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF) – Report on antiarrhythmic drug therapy
by: Yuji Murakawa, MD, et al.
Published: (2014-10-01)

Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry
by: L. E. Korobchenko, et al.
Published: (2020-06-01)

Restitution Slope Affects the Outcome of Dominant Frequency Ablation in Persistent Atrial Fibrillation: CUVIA-AF2 Post-Hoc Analysis Based on Computational Modeling Study
by: Je-Wook Park, et al.
Published: (2022-03-01)

ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS
by: T. A. Rybakova, et al.
Published: (2018-08-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Anti-atrial Fibrillation Effects of Pulmonary Vein Isolation With or Without Ablation Gaps: A Computational Modeling Study
by: Ze Jin, et al.
Published: (2022-03-01)

Antiarrhythmic or time bomb? A severe iatrogenic bradyarrhythmia
by: S. Matheou, et al.
Published: (2013-05-01)

Impact of Antiarrhythmic Drugs on Complex Fractionated Atrial Electrograms
by: Koichiro Kumagai, MD, et al.
Published: (2011-01-01)

Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation—Insights from the German Ablation Registry
by: Ruben Schleberger, et al.
Published: (2021-12-01)

Comparison of the 11-Day Adhesive ECG Patch Monitor and 24-h Holter Tests to Assess the Response to Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation
by: Soohyun Kim, et al.
Published: (2023-09-01)

Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
by: M. H. Fedorova, et al.
Published: (2018-11-01)

Clinical and genetic relationships between the QTc interval and risk of a stroke among atrial fibrillation patients undergoing catheter ablation
by: Myunghee Hong, et al.
Published: (2020-06-01)

Corrigendum: Association of ZFHX3 genetic polymorphisms and extrapulmonary vein triggers in patients with atrial fibrillation who underwent catheter ablation
by: Inseok Hwang, et al.
Published: (2022-12-01)

Association of ZFHX3 Genetic Polymorphisms and Extra-Pulmonary Vein Triggers in Patients With Atrial Fibrillation Who Underwent Catheter Ablation
by: Inseok Hwang, et al.
Published: (2022-01-01)

Blanking period antiarrhythmic drugs after catheter ablation for atrial fibrillation: a meta-analysis of randomized controlled trials
by: Gang Chen, et al.
Published: (2023-07-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
by: K. A. Skiba, et al.
Published: (2003-06-01)

Comparing monopharmacotherapy of antiarrhythmic and anticoagulant drugs with other drugs for atrial fibrillation: A complete review of clinical trials
by: Akshat D. Modi, et al.
Published: (2023-06-01)

Clinical Characteristics and Rhythm Outcomes in Patients With Atrial Myopathy After Successful Catheter Ablation of Atrial Fibrillation
by: Moon‐Hyun Kim, et al.
Published: (2024-02-01)

Pediatric antiarrhythmics and toxicity: A clinical review
by: Alexandra T. Geanacopoulos, et al.
Published: (2024-02-01)

Efficiency and safety of using the modified protocol for the administration of the domestic class III antiarrhythmic drug for the relief of paroxysmal atrial fibrillation
by: Khava M. Dzaurova, et al.
Published: (2021-09-01)

Long‐Term Outcome of Additional Superior Vena Cava to Septal Linear Ablation in Catheter Ablation of Atrial Fibrillation
by: Moo‐Nyun Jin, et al.
Published: (2019-11-01)

Pharmacologic Therapy in the Elderly with Atrial Fibrillation
by: Shih-Huang Lee, et al.
Published: (2008-03-01)

Lower pulmonary vein-to-left atrium volume ratio predicts poor rhythm outcome after atrial fibrillation catheter ablation
by: Jae-Hyuk Lee, et al.
Published: (2022-07-01)

Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease
by: D. A. Tsaregorodtsev, et al.
Published: (2023-05-01)

Transvenous, intracardial cardioversion for the treatment of postoperative atrial fibrillation
by: Fitzgerald Robert, et al.
Published: (2008-01-01)

Effect of epicardial fat volume on outcomes after left atrial posterior wall isolation in addition to pulmonary vein isolation in patients with persistent atrial fibrillation
by: Daehoon Kim, et al.
Published: (2022-10-01)

Pharmacological Therapy for Fibrillations
by: Akira Fujiki, MD
Published: (2007-01-01)

Does Additional Electrogram‐Guided Ablation After Linear Ablation Reduce Recurrence After Catheter Ablation for Longstanding Persistent Atrial Fibrillation? A Prospective Randomized Study
by: Tae‐Hoon Kim, et al.
Published: (2017-02-01)

Impact of the COVID-19 Pandemic and Public Restrictions on Outcomes After Catheter Ablation of Atrial Fibrillation
by: Daehoon Kim, et al.
Published: (2022-03-01)

ATRIAL FIBRILLATION: CURRENT PROBLEMS AND PROSPECTS OF MEDICAL CARE, TREATMENT AND PREVENTION
by: Ju. P. Skirdenko, et al.
Published: (2016-05-01)

Corrigendum: Effect of epicardial fat volume on outcomes after left atrial posterior wall isolation in addition to pulmonary vein isolation in patients with persistent atrial fibrillation
by: Daehoon Kim, et al.
Published: (2023-06-01)